Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 88.1435 | 73 |
GSM780708 | Untreated after 4 days (C2_1) | 98.6433 | 75 |
GSM780709 | Untreated after 4 days (C3_1) | 85.5546 | 73 |
GSM780719 | Untreated after 4 days (C1_2) | 77.0959 | 71 |
GSM780720 | Untreated after 4 days (C2_2) | 110.757 | 77 |
GSM780721 | Untreated after 4 days (C3_2) | 75.3707 | 71 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 100.61 | 75 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 94.8397 | 74 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 99.3043 | 75 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 106.529 | 76 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 90.8835 | 74 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 93.9372 | 74 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 99.3763 | 75 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 81.3915 | 72 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 83.0091 | 72 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 71.1861 | 69 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 79.3577 | 72 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 83.968 | 73 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 144.755 | 80 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 114.481 | 77 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 97.9459 | 75 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 113.701 | 77 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 108.542 | 76 |